Paid Clinical Trials in Fountain Valley, CA
As of August 2026, 100 paid clinical trials are recruiting in Fountain Valley, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fountain Valley offers studies at sites including Ark Clinical Research - Fountain Valley for conditions such as Atopic Dermatitis, Plaque Psoriasis, Breast Cancer, Non-Small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Fountain Valley
Trials by drug in Fountain Valley
Filter results
Newly added in Fountain Valley
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
96 clinical trials
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
A Study of Brenipatide in Participants With Opioid Use Disorder
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study of Buntanetap in Participants With PD
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Galleri® in the Medicare Population.
Top Research Study Locations in Fountain Valley
Researchers run research studies in Fountain Valley, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Ark Clinical Research - Fountain Valley | Atherosclerotic Cardiovascular Disease (ASCVD), Cortisol Excess, Elevated Lp(a) | 8 |
| First OC Dermatology | Atopic Dermatitis, Chronic Spontaneous Urticaria (CSU), Eczema | 8 |
| MemorialCare Orange Coast Medical Center | AMI, Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung | 6 |
| Ark Clinical Research | Body Weight, Diabetes Mellitus, Type 2, Nutrition Disorders | 5 |
| First OC Dermatology Research Inc | Chronic Spontaneous Urticaria, Hidradenitis Suppurativa, Overweight or Obesity | 3 |
| First OC Dermatology Research Inc. | Psoriatic Arthritis, Plaque Psoriasis | 3 |
| Orange Coast Memorial Medical Center | Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer, Stage III Colon Cancer | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Los Angeles Cancer Network | Adenocarcinoma of Lung, Breast Cancer, Breast Neoplasms | 2 |
| Memorial Health Services | Atrial Fibrillation, Pediatric Migraine, Stroke, Ischemic | 2 |
| MemorialCare | Colorectal Cancer, Non-Small Cell Lung Cancer | 2 |
| Neurocrine Clinical Site | Tardive Dyskinesia, Bipolar Disorder, Major Depressive Disorder | 2 |
| Oruka Therapeutics Investigative Site | Plaque Psoriasis | 2 |
| The Parkinson's & Movement Disorder Institute | Parkinson Disease, Parkinson's Disease | 2 |
| Galderma Investigational | Prurigo Nodularis, Atopic Dermatitis | 2 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| ARK Clinical Research, LLC | Chikungunya Virus | 1 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH - Nonalcoholic Steatohepatitis | 1 |
| Central Recruiting Site | Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain, Chemotherapy Induced Pain Neuropathy | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer | 1 |
| Compassionate Cancer Care Center | Non-small Cell Lung Cancer (NSCLC) | 1 |
| Compassionate Cancer Care Medical Group | Refractory Diffuse Large B-cell Lymphoma, Relapsed Diffuse Large B-cell Lymphoma | 1 |
| Compassionate Cancer Care Medical Group - Inc | Triple Negative Breast Cancer | 1 |
| Compassionate Care Research Group | Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes | 1 |
Active & Upcoming Studies in Fountain Valley (2026)
Recruiting trials in Fountain Valley grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (34 active studies)
- A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer) · Phase 3 · Genentech, Inc.
- BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease · Phase 3 · BeOne Medicines
Diabetes & metabolic (12 active studies)
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes · Phase 2 · Novo Nordisk A/S
Neurology & pain (4 active studies)
- Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease · Phase 2 · Hillhurst Biopharmaceuticals, Inc.
- Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain · Phase 2 · Dogwood Therapeutics Inc.
Cardiovascular (3 active studies)
- A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation · Biosense Webster, Inc.
- A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System · Biosense Webster, Inc.
Pediatric (2 active studies)
Mental health & behavior (1 active study)
Eye & vision (1 active study)
- Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications · University of California, Los Angeles
Common conditions studied in Fountain Valley
- Atopic Dermatitis (6 active studies)
- Plaque Psoriasis (5 active studies)
- Breast Cancer (4 active studies)
- Non-Small Cell Lung Cancer (4 active studies)
- Atrial Fibrillation (3 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
Leading research sponsors in Fountain Valley
- AstraZeneca
- Eli Lilly and Company
- Pfizer
- Takeda
- Bristol-Myers Squibb
Frequently asked questions
How many paid clinical trials are currently recruiting in Fountain Valley?
There are approximately 100 recruiting clinical trials in Fountain Valley, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fountain Valley pay participants?
Most recruiting trials in Fountain Valley compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fountain Valley?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fountain Valley?
The most common conditions under active study in Fountain Valley include Atopic Dermatitis (6), Plaque Psoriasis (5), Breast Cancer (4), Non-Small Cell Lung Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fountain Valley?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fountain Valley on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fountain Valley?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fountain Valley?
Recruiting research sites in Fountain Valley include Ark Clinical Research - Fountain Valley, First OC Dermatology, MemorialCare Orange Coast Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fountain Valley right now?
The largest active categories in Fountain Valley are Cancer & tumors (34), Diabetes & metabolic (12), Neurology & pain (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.